CMA employs comparative genomic hybridization or SNP arrays to analyze the genome for copy number variations (CNVs). During the process, DNA from a patient sample is labeled and hybridized onto a microarray chip containing thousands of DNA probes. The results are then compared to a reference genome to identify any genetic imbalances.
